v3.26.3
Condensed Consolidated Statements of Redeemable Convertible Noncontrolling Interests and Stockholders' Deficit (Unaudited) - USD ($)
$ in Thousands
Total
Total BridgeBio Stockholders’ Deficit
Preferred Stock
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non- controlling Interests
Temporary equity, beginning balance at Dec. 31, 2024 [1] $ 142                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of noncontrolling interests 800                
Transfers from (to) noncontrolling interests 379                
Net loss (1,548)                
Temporary equity, ending balance at Mar. 31, 2025 (227)                
Beginning balance (in shares) at Dec. 31, 2024 [1]       190,044,473          
Beginning balance at Dec. 31, 2024 [1] (1,457,754) $ (1,467,904)   $ 196 $ (275,000) $ 1,903,155 $ 8 $ (3,096,263) $ 10,150
Beginning balance (in shares) at Dec. 31, 2024 [1]         6,191,761        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of common stock (in shares)       (1,405,411) 1,405,411        
Repurchase of common stock (48,276) (48,276)     $ (48,276)        
Issuance of shares under equity compensation plans (in shares)       1,081,744          
Issuance of shares under equity compensation plans 2,521 2,521   $ 1   2,520      
Issuance of common stock under employee stock purchase plan ESPP (in shares)       156,097          
Issuance of common stock under employee stock purchase plan (ESPP) 3,237 3,237       3,237      
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding, (in shares)       (50,880)          
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding (1,776) (1,776)       (1,776)      
Stock-based compensation 32,057 32,057       32,057      
Transfers from (to) noncontrolling interests (379) (824)       (824)     445
Unrealized (loss) gain on available-for-sale securities (8) (8)         (8)    
Net loss (168,060) (167,422)           (167,422) (638)
Ending balance (in shares) at Mar. 31, 2025       189,826,023          
Ending balance at Mar. 31, 2025 (1,638,438) (1,648,395)   $ 197 $ (323,276) 1,938,369 0 (3,263,685) 9,957
Ending balance (in shares) at Mar. 31, 2025         7,597,172        
Temporary equity, beginning balance at Dec. 31, 2024 [1] 142                
Temporary equity, ending balance at Sep. 30, 2025 23                
Beginning balance (in shares) at Dec. 31, 2024 [1]       190,044,473          
Beginning balance at Dec. 31, 2024 [1] (1,457,754) (1,467,904)   $ 196 $ (275,000) 1,903,155 8 (3,096,263) 10,150
Beginning balance (in shares) at Dec. 31, 2024 [1]         6,191,761        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Unrealized (loss) gain on available-for-sale securities (6)                
Ending balance (in shares) at Sep. 30, 2025       192,633,286          
Ending balance at Sep. 30, 2025 (1,922,752) (1,933,070)   $ 200 $ (323,276) 2,018,335 2 (3,628,331) 10,318
Ending balance (in shares) at Sep. 30, 2025         7,597,172        
Temporary equity, beginning balance at Mar. 31, 2025 (227)                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of noncontrolling interests 750                
Transfers from (to) noncontrolling interests 400                
Net loss (1,368)                
Temporary equity, ending balance at Jun. 30, 2025 (445)                
Beginning balance (in shares) at Mar. 31, 2025       189,826,023          
Beginning balance at Mar. 31, 2025 (1,638,438) (1,648,395)   $ 197 $ (323,276) 1,938,369 0 (3,263,685) 9,957
Beginning balance (in shares) at Mar. 31, 2025         7,597,172        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of shares under equity compensation plans (in shares)       1,395,587          
Issuance of shares under equity compensation plans 7,159 7,159   $ 1   7,158      
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding, (in shares)       (58,951)          
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding (1,995) (1,995)       (1,995)      
Stock-based compensation 38,089 38,089       38,089      
Transfers from (to) noncontrolling interests (400) (816)       (816)     416
Unrealized (loss) gain on available-for-sale securities 1 1         1    
Net loss (182,390) (181,903)           (181,903) (487)
Ending balance (in shares) at Jun. 30, 2025       191,162,659          
Ending balance at Jun. 30, 2025 (1,777,974) (1,787,860)   $ 198 $ (323,276) 1,980,805 1 (3,445,588) 9,886
Ending balance (in shares) at Jun. 30, 2025         7,597,172        
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Transfers from (to) noncontrolling interests 2,068                
Net loss (1,600)                
Temporary equity, ending balance at Sep. 30, 2025 23                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of shares under equity compensation plans (in shares)       1,424,255          
Issuance of shares under equity compensation plans 4,843 4,843   $ 2   4,841      
Issuance of common stock under employee stock purchase plan ESPP (in shares)       105,325          
Issuance of common stock under employee stock purchase plan (ESPP) 3,177 3,177       3,177      
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding, (in shares)       (58,953)          
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding (3,025) (3,025)       (3,025)      
Stock-based compensation 35,631 35,631       35,631      
Transfers from (to) noncontrolling interests (2,068) (3,094)       (3,094)     1,026
Unrealized (loss) gain on available-for-sale securities 1 1         1    
Net loss (183,337) (182,743)           (182,743) (594)
Ending balance (in shares) at Sep. 30, 2025       192,633,286          
Ending balance at Sep. 30, 2025 (1,922,752) (1,933,070)   $ 200 $ (323,276) 2,018,335 2 (3,628,331) 10,318
Ending balance (in shares) at Sep. 30, 2025         7,597,172        
Temporary equity, beginning balance at Dec. 31, 2025 [2] (570)                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Transfers from (to) noncontrolling interests 1,489                
Net loss (1,870)                
Temporary equity, ending balance at Mar. 31, 2026 (951)                
Beginning balance (in shares) at Dec. 31, 2025 [2]     0            
Beginning balance at Dec. 31, 2025 $ (2,086,610) [3]   $ 0 [2]            
Beginning balance (in shares) at Dec. 31, 2025 194,771,957     194,771,957 [2]          
Beginning balance at Dec. 31, 2025 [2] $ (2,076,011) [3] (2,086,610)   $ 202 $ (323,276) 2,057,646 12 (3,821,194) 10,599
Beginning balance (in shares) at Dec. 31, 2025 7,597,172       7,597,172 [2]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of common stock (in shares)       (1,081,825) 1,081,825        
Repurchase of common stock $ (82,500) (82,500)     $ (82,500)        
Issuance of shares under equity compensation plans (in shares)       1,940,523          
Issuance of shares under equity compensation plans 22,589 22,589   $ 2   22,587      
Issuance of common stock under employee stock purchase plan ESPP (in shares)       131,185          
Issuance of common stock under employee stock purchase plan (ESPP) 5,466 5,466       5,466      
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding, (in shares)       (54,138)          
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding (4,074) (4,074)       (4,074)      
Stock-based compensation 32,784 32,784       32,784      
Issuance of noncontrolling interests 16               16
Transfers from (to) noncontrolling interests (1,489) (1,955)       (1,955)     466
Unrealized (loss) gain on available-for-sale securities (20) (20)         (20)    
Net loss (164,685) (164,043)           (164,043) (642)
Ending Balance (in shares) at Mar. 31, 2026     0            
Ending balance at Mar. 31, 2026     $ 0            
Ending balance (in shares) at Mar. 31, 2026       195,707,702          
Ending balance at Mar. 31, 2026 (2,267,924) (2,278,363)   $ 204 $ (405,776) 2,112,454 (8) (3,985,237) 10,439
Ending balance (in shares) at Mar. 31, 2026         8,678,997        
Temporary equity, beginning balance at Dec. 31, 2025 [2] (570)                
Temporary equity, ending balance at Sep. 30, 2026 (1,363)                
Beginning balance (in shares) at Dec. 31, 2025 [2]     0            
Beginning balance at Dec. 31, 2025 $ (2,086,610) [3]   $ 0 [2]            
Beginning balance (in shares) at Dec. 31, 2025 194,771,957     194,771,957 [2]          
Beginning balance at Dec. 31, 2025 [2] $ (2,076,011) [3] (2,086,610)   $ 202 $ (323,276) 2,057,646 12 (3,821,194) 10,599
Beginning balance (in shares) at Dec. 31, 2025 7,597,172       7,597,172 [2]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Unrealized (loss) gain on available-for-sale securities $ (107)                
Ending Balance (in shares) at Sep. 30, 2026     933,900            
Ending balance at Sep. 30, 2026 $ (1,662,342)   $ 942,478            
Ending balance (in shares) at Sep. 30, 2026 196,004,842     196,004,842          
Ending balance at Sep. 30, 2026 $ (1,652,142) (1,662,342)   $ 207 $ (580,775) 2,170,006 (95) (4,194,163) 10,200
Ending balance (in shares) at Sep. 30, 2026 11,295,163       11,295,163        
Temporary equity, beginning balance at Mar. 31, 2026 $ (951)                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Transfers from (to) noncontrolling interests 2,682                
Net loss (2,749)                
Temporary equity, ending balance at Jun. 30, 2026 (1,018)                
Beginning balance (in shares) at Mar. 31, 2026     0            
Beginning balance at Mar. 31, 2026     $ 0            
Beginning balance (in shares) at Mar. 31, 2026       195,707,702          
Beginning balance at Mar. 31, 2026 (2,267,924) (2,278,363)   $ 204 $ (405,776) 2,112,454 (8) (3,985,237) 10,439
Beginning balance (in shares) at Mar. 31, 2026         8,678,997        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of common stock (in shares)       (1,904,001) 1,904,001        
Repurchase of common stock (127,503) (127,503)     $ (127,503)        
Issuance of shares under equity compensation plans (in shares)       1,545,170          
Issuance of shares under equity compensation plans 5,223 5,223   $ 2   5,221      
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding, (in shares)       (64,519)          
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding (4,267) (4,267)       (4,267)      
Stock-based compensation 45,419 45,419       45,419      
Transfers from (to) noncontrolling interests (2,682) (3,509)       (3,509)     827
Unrealized (loss) gain on available-for-sale securities 1 1         1    
Net loss (153,142) (152,216)           (152,216) (926)
Ending Balance (in shares) at Jun. 30, 2026     0            
Ending balance at Jun. 30, 2026     $ 0            
Ending balance (in shares) at Jun. 30, 2026       195,284,352          
Ending balance at Jun. 30, 2026 (2,504,875) (2,515,215)   $ 206 $ (533,279) 2,155,318 (7) (4,137,453) 10,340
Ending balance (in shares) at Jun. 30, 2026         10,582,998        
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Transfers from (to) noncontrolling interests 2,500                
Net loss (2,845)                
Temporary equity, ending balance at Sep. 30, 2026 (1,363)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of common stock (in shares)       (712,165) 712,165        
Repurchase of common stock (47,496) (47,496)     $ (47,496)        
Issuance of preferred stock, net of issuance costs (in shares)     933,900            
Issuance of preferred stock, net of issuance costs 932,558 932,558 $ 932,558            
Accretion of preferred stock 0   $ 9,920     (9,920)      
Preferred stock dividends (16,373) (16,373)       (16,373)      
Issuance of shares under equity compensation plans (in shares)       1,430,282          
Issuance of shares under equity compensation plans 5,900 5,900   $ 1   5,899      
Issuance of common stock under employee stock purchase plan ESPP (in shares)       66,105          
Issuance of common stock under employee stock purchase plan (ESPP) 4,262 4,262       4,262      
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding, (in shares)       (63,732)          
Repurchase of restricted stock unit (RSU) shares to satisfy tax withholding (5,090) (5,090)       (5,090)      
Stock-based compensation 39,211 39,211       39,211      
Transfers from (to) noncontrolling interests (2,500) (3,301)       (3,301)     801
Unrealized (loss) gain on available-for-sale securities (88) (88)         (88)    
Net loss (57,651) (56,710)           (56,710) (941)
Ending Balance (in shares) at Sep. 30, 2026     933,900            
Ending balance at Sep. 30, 2026 $ (1,662,342)   $ 942,478            
Ending balance (in shares) at Sep. 30, 2026 196,004,842     196,004,842          
Ending balance at Sep. 30, 2026 $ (1,652,142) $ (1,662,342)   $ 207 $ (580,775) $ 2,170,006 $ (95) $ (4,194,163) $ 10,200
Ending balance (in shares) at Sep. 30, 2026 11,295,163       11,295,163        
[1] The consolidated balances as of December 31, 2025 and 2024 are derived from the audited consolidated financial statements as of those dates.
[2] The consolidated balances as of December 31, 2025 and 2024 are derived from the audited consolidated financial statements as of those dates.
[3] The condensed consolidated balance sheet as of December 31, 2025 is derived from the audited consolidated financial statements as of that date.